ArticleThe oncologist2026

Molecular tumor board-guided osimertinib therapy in EGFR L858R/Q701L-mutant lung adenocarcinoma supported by functional validation.

Corinna Albers-Leischner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.